Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients

Diabetic Medicine

Volumn 19, Issue 2, 2002, Pages 136-143

  Abbink, E J ^a   Pickkers, P ^a   Jansen Van Rosendaal, A ^a   Lutterman, J A ^a   Tack, C J ^a   Russel, F G M ^a   Smits, P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Glibenclamide; Glimepiride; KATP channels; Metformin; Venous occlusion plethysmography

Indexed keywords

ACETYLCHOLINE; DIAZOXIDE; DIPYRIDAMOLE; ENDOTHELIUM DERIVED RELAXING FACTOR; GLIBENCLAMIDE; GLIMEPIRIDE; METFORMIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOREARM BLOOD FLOW; HUMAN; LIMB ISCHEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ACETYLCHOLINE; ADULT; AGED; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; C-PEPTIDE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIAZOXIDE; DIPYRIDAMOLE; DOUBLE-BLIND METHOD; FEMALE; FOREARM; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; SULFONYLUREA COMPOUNDS; VASODILATION;

EID: 0036122919     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00663.x     Document Type: Article

References (31)

1. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study
2. Diabetic retinopathy and cardiovascular disease in type II diabetics. The Framingham Heart Study and the Framingham Eye Study
3. Sulfonylureas in NIDDM
4. Oral hypoglycemic agents
5. ATP-regulated K+ channels in cardiac muscle
6. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle
7. Potassium channel openers and vascular smooth muscle relaxation
8. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction
9. Hyperpolarization and relaxation of resistance arteries in response to adenosine diphosphate. Distribution and mechanism of action
10. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage
11. Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: Antagonism by glibenclamide
12. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation
13. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
14. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans
15. Blockade of vascular ATP-sensitive potassium channels reduces the vasodilator response to ischaemia in humans
16. Extrapancreatic effects of sulfonylureasa - A comparison between glimepiride and conventional sulfonylureas
17. Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide
18. Metformin improves peripheral vascular flow in nonhyperlipidemic patients with arterial disease
19. The measurement of volume changes in human limbs
20. Caffeine and theophylline attenuate adenosine-induced vasodilation in humans
21. Role of the wrist cuff in forearm plethysmography
22. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels
23. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone
24. Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes
25. Maximal post-ischaemic forearm vasodilation in human hypertension: A re-assessment of the method
26. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
27. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose
28. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo
29. Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients
30. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
31. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus